optimizing therapy for moderate to severe ibd
Published 8 months ago • 158 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
24:18
optimizing therapy for mild to moderate ibd
-
21:59
the treatment of moderate to severe ibd with anti-tnf biologics and immunomodulators
-
53:58
optimizing therapy for inflammatory bowel disease: current and emerging treatments
-
12:04
pro: vedolizumab should be used before anti-tnfs for moderate to severe ibd
-
10:25
con: anti-tnfs should be used before vedolizumab for moderate to severe ibd
-
22:21
ulcerative colitis: recent and emerging therapies
-
21:14
when and how to use immunomodulators and biologics in ibd
-
34:01
choosing and optimizing therapy today while preparing for tomorrow
-
17:23
evolving approaches to ibd management: from step-care to treat-to-target
-
26:15
improving patient outcomes in moderate-to-severe ulcerative colitis
-
21:30
ibd: beyond combination therapy
-
18:01
key insights: reaching beyond anti-tnfs in moderate to severe ulcerative colitis
-
20:48
defining an ibd patient's disease severity and prognosis
-
31:22
success factors in the treatment of mild-to-moderate uc by dr ailsa hart
-
15:15
first line therapies for ulcerative colitis and crohn's disease
-
31:09
emerging therapies in ibd - dr. hanauer
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease
-
34:19
update in medical and surgical therapy for inflammatory bowel disease -- ep. 4